发明授权
US07964725B2 Heteroarylbenzamide derivatives for use in the treatment of diabetes
失效
用于治疗糖尿病的杂芳基苯甲酰胺衍生物
- 专利标题： Heteroarylbenzamide derivatives for use in the treatment of diabetes
- 专利标题（中）： 用于治疗糖尿病的杂芳基苯甲酰胺衍生物
-
申请号： US12644249申请日： 2009-12-22
-
公开(公告)号： US07964725B2公开(公告)日： 2011-06-21
- 发明人: Nathaniel George Martin , Darren Mckerrecher , Kurt Gordon Pike , Michael James Waring
- 申请人： Nathaniel George Martin , Darren Mckerrecher , Kurt Gordon Pike , Michael James Waring
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 代理机构： Morgan Lewis & Bockius LLP
- 主分类号： C07D241/08
- IPC分类号： C07D241/08
摘要：
The invention relates to a novel group of compounds of Formula (I) or a salt thereof: wherein R1, R2, R3, n, A and HET-1 are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK) such as type 2 diabetes. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by GLK using said compounds and methods for preparing compounds of Formula (I).
公开/授权文献
- US20100173825A1 HETEROARYL BENZAMIDE DERIVATIVES 公开/授权日：2010-07-08
信息查询
